Institut Curie

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer (2026) Bidard FC, Barrios C, Bianchini G, Brufsky AM, Chia S, Cortes J, Cristofanilli M, et al. Journal article SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy (2026) Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, et al. Journal article ESTRO consensus recommendations on total skin electron beam technique - Endorsed by ILROG (2026) Moustakis C, Wahlstedt IH, Platoni KP, Lim TY, González MAV, Hernández TG, Levis M, et al. Journal article Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial (2026) Turner NC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility (2026) Larue L, Barral DC, Delmas V, Egea-Rodriguez S, Aldea D, Etchevers HC, Galibert MD, et al. Journal article Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC (2026) Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, et al. Journal article Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer (2026) Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, et al. Journal article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy (2026) Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, et al. Journal article